Query: NC_008825:3298506 Methylibium petroleiphilum PM1, complete genome Lineage: Methylibium petroleiphilum; Methylibium; ; Burkholderiales; Proteobacteria; Bacteria General Information: Methylibium petroleiphilum strain PM1 (ATCC BAA-1232) was isolated in 1998 from the biofilter of a treatment plant in an oil refinery in Los Angeles, California, USA. Strain PM1 is capable of degrading aromatic compounds such as benzene, toluene and xylenes. Methyl tertiary-butyl ether-degrading bacterium. Methylibium petroleiphilum is a methylotroph (able to utilize reduced one-carbon compounds) able to degrade methyl tertiary-butyl ether (MTBE) under aerobic conditions. MTBE is a gasoline additive used as an oxygenate and to raise the octane number.
- Sequence; - BLASTP hit: hover for score (Low score = Light, High score = Dark); - hypothetical protein; - cds: hover for description
General Information: This organism was discovered in 1819 by Bizio who named the organism after the Italian physicist Serrati. It was considered a nonpathogenic organism until late in the 20th century, although pathogenicity was noted as early as 1913. Serratia marcescens is an opportunistic human pathogen that is increasingly associated with life-threatening hospital-acquired infections. It is an environmental organism that has a broad host range, and is capable of infecting vertebrates and invertebrates, as well as plants. In humans, Serratia marcescens can cause meningitis (inflammation of the membrane surrounding the brain and spinal cord), endocarditis (inflammation of heart muscle) and pyelonephritis (inflammation of the kidneys). Many strains are resistant to multiple antibiotics. Environmental isolates are noted by production of the red pigment prodigiosin.